BRCA1 and BRCA2 genetic testing - pitfalls and recommendations for managing variants of uncertain clinical significance
Background Increasing use of BRCA1/2 testing for tailoring cancer treatment and extension of testing to tumour tissue for somatic mutation is moving BRCA1/2 mutation screening from a primarily prevention arena delivered by specialist genetic services into mainstream oncology practice. A considerabl...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2015-10-10.
|
| Subjects: | |
| Online Access: | Get fulltext |